Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,387 | 5,328 | 8,010 | 11,465 | 17,939 |
| Marketable Securities | N/A | N/A | N/A | N/A | 994 |
| Receivables | 2,231 | 1,073 | 146 | 9 | 31 |
| Inventories | 1,436 | 932 | 360 | N/A | N/A |
| Other current assets | 1,053 | 741 | 782 | 764 | 788 |
| TOTAL | $18,107 | $8,074 | $9,298 | $12,238 | $19,752 |
| Non-Current Assets | |||||
| PPE Net | 2,820 | 3,062 | 3,270 | 3,432 | 3,639 |
| Investments And Advances | 344 | 352 | 360 | 369 | 77 |
| Intangibles | 4,834 | 4,889 | 4,945 | 5,000 | 5,056 |
| Other Non-Current Assets | 563 | 553 | 507 | 468 | 425 |
| TOTAL | $8,561 | $8,856 | $9,082 | $9,269 | $9,197 |
| Total Assets | $26,668 | $16,930 | $18,380 | $21,507 | $28,949 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 370 | 483 | 601 | 721 | 692 |
| Accounts payable and accrued liabilities | 6,627 | 6,837 | 6,707 | 7,349 | 4,901 |
| TOTAL | $6,997 | $7,320 | $7,308 | $8,070 | $5,593 |
| Non-Current Liabilities | |||||
| Long Term Debt | 112 | 129 | 184 | 237 | 444 |
| Other Non-Current Liabilities | 1,200 | 1,000 | 1,200 | 1,000 | 1,000 |
| TOTAL | $21,984 | $21,808 | $22,136 | $22,837 | $23,118 |
| Total Liabilities | $28,981 | $29,128 | $29,444 | $30,907 | $28,711 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,256 | 26,394 | 26,104 | 25,104 | 24,039 |
| Common Shares | 31 | 28 | 27 | 26 | 26 |
| Retained earnings | -155,636 | -148,818 | -140,405 | -132,132 | -121,452 |
| Other shareholders' equity | 206 | 206 | 206 | 202 | 206 |
| TOTAL | $-2,313 | $-12,198 | $-11,064 | $-9,400 | $238 |
| Total Liabilities And Equity | $26,668 | $16,930 | $18,380 | $21,507 | $28,949 |